This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,268,322
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
CIHR · 2025 · Principal investigator
- $100,000
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
CIHR · 2023 · Principal investigator
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
Principal investigators: Grandi, Sonia; Longo, Cristina M
Keywords: Biologics; Child Outcomes; Drug Effectiveness; Drug Safety; Infant Outcomes; Maternal Health; Pharmacoepidemiology; Population-Based Data; Pregnancy
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
Principal investigators: Grandi, Sonia; Longo, Cristina M
Keywords: Biologics; Child Outcomes; Drug Effectiveness; Drug Safety; Infant Outcomes; Maternal Health; Pharmacoepidemiology; Population-Based Data; Pregnancy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.